Mark Mullikin, based in Boston, MA, US, is currently a Chief Financial Officer at Ensem Therapeutics. Mark Mullikin brings experience from previous roles at Value Creation Partners, Vedanta Biosciences, Inc. and Editas Medicine. Mark Mullikin holds a MBA in Finance & Accounting @ MIT Sloan School of Management. With a robust skill set that includes Lifesciences, Financial Modeling, Pharmaceutical Industry, Competitive Analysis, Business Development and more. Mark Mullikin has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mark Mullikin?
Find contact details for 700 million professionals.